Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus
- PMID: 34526902
- PMCID: PMC8435730
- DOI: 10.3389/fphar.2021.724725
Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus
Abstract
Mycobacterium abscessus has been recognised as a dreadful respiratory pathogen among the non-tuberculous mycobacteria (NTM) because of misdiagnosis, prolonged therapy with poor treatment outcomes and a high cost. This pathogen also shows extremely high antimicrobial resistance against current antibiotics, including the anti-tuberculosis agents. Therefore, current chemotherapies require a long curative period and the clinical outcomes are not satisfactory. Thus, there is an urgent need for discovering and developing novel, more effective anti-M. abscessus drugs. In this review, we sum the effectiveness of the current anti-M. abscessus drugs and drug candidates. Furthermore, we describe the shortcomings and difficulties associated with M. abscessus drug discovery and development.
Keywords: Mycobacterium abscessus; anti-M. abscessus; antibiotics; drug discovery; drug resistance.
Copyright © 2021 Quang and Jang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases